VOR icon

Vor Biopharma

59 hedge funds and large institutions have $326M invested in Vor Biopharma in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
0.94%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
8
Increased
25
Reduced
10
Closed
7
Calls
$103K
Puts
$6K
Net Calls
+$97K
Net Calls Change
-$78K
Name Holding Trade Value Shares
Change
Shares
Change %
Balyasny Asset Management
51
Balyasny Asset Management
Illinois
$67.9K +$67.9K +12,627 New
Bank of New York Mellon
52
Bank of New York Mellon
New York
$65.9K
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
$61.8K -$212K -39,423 -77%
JF
54
Jump Financial
Illinois
$55.6K +$55.6K +10,329 New
DA
55
Denali Advisors
California
$35K +$35K +6,500 New
Nisa Investment Advisors
56
Nisa Investment Advisors
Missouri
$21K
Lazard Asset Management
57
Lazard Asset Management
New York
$10K +$1.96K +393 +24%
Northwestern Mutual Wealth Management
58
Northwestern Mutual Wealth Management
Wisconsin
$1.35K
Wells Fargo
59
Wells Fargo
California
$1.19K +$570 +106 +91%
EBA
60
Eagle Bay Advisors
New York
$807
AIC
61
AWM Investment Company
New York
-$665K -100,000 Closed
TRCT
62
Tower Research Capital (TRC)
New York
-$172K -25,881 Closed
E
63
Ergoteles
New York
-$152K -22,858 Closed
Simplex Trading
64
Simplex Trading
Illinois
-$46K -7,048 Closed
UBS Group
65
UBS Group
Switzerland
-$27.2K -4,087 Closed
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
-$6K -838 Closed